Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Emerging risk factors for stroke: Deciphering the biological mechanisms underlying the impact of chronic stress on the microbiome and microglia epigenetics.

Project description

Linking stress, gut microbiota and stroke risk

Ischaemic stroke is a devastating disease and a leading cause of long-term disability worldwide. Growing evidence indicates that the gut microbiota can influence ischaemic brain damage, while chronic stress can alter gut microbiota composition and function and has been linked to brain disorders. Supported by the Marie Skłodowska-Curie Actions programme, the MicroStress project will test the hypothesis that chronic stress modifies the microbiota response to stroke, thereby exacerbating brain injury. Using advanced molecular and in vivo approaches, including metagenomic, metabolomic and epigenetic analyses, the project will investigate how stress-induced microbiota changes affect brain-resident microglia and stroke severity. The findings could contribute to new preventive and therapeutic strategies for stroke.

Objective

According to the World Stroke Organization (WSO), stroke is the third-leading cause of death and disability worldwide, with an estimated total cost of €60 billion in Europe. The number of people living with stroke is estimated to increase of 27% within 2047. In the last years, an increased incidence of stroke was observed among younger population, due to exposure to emerging risk factors such as stress. The leading role of the gut microbiota in stroke outcome has been demonstrated by the pioneering works conducted by Dr. Benakis, supervisor at the host Institute for Stroke and Dementia (ISD), showing that microbiota can influence brain damage severity. During my Ph.D. I demonstrated that stress exposure leads to alteration in microbiota composition, resulting in the production and accumulation in the brain of the microbial-derived uremic toxin p-cresol, which has been associated with an increased incidence of ischemic stroke. However, there are currently no studies exploring the correlation between stress, microbiota, and stroke, leaving a great gap that could have substantial clinical implications. The MicroStress project aims to investigate, for the first time, the relationship between chronic stress and stroke through microbiota alteration, combining in vivo and molecular cutting-edge technologies including metabolomic and epigenetic assays. Moreover, this project proposes a therapeutic approach using synbiotic – a mixture of probiotic and prebiotic – to modify microbiota composition and ameliorate stroke outcome. The combination of Dr. Benakis’ expertise in the microbiota-immune system-stroke interaction and my experience in stress-microbiota research will be fundamental to closing this gap. The MicroStress project is a unique opportunity to acquire new scientific and transferable skills, essential for achieving the project’s objectives and advancing towards an independent research career.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Net EU contribution
€ 202 125,12
Address
GESCHWISTER SCHOLL PLATZ 1
80539 Planegg
Germany
Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data